Post-Doc Researcher:
joining soon Research Outline: Bioinspired total synthesis and medicinal chemistry studies of complex natural products including prostanoids, terpenoids, indole alkaloids, etc. |
Graduate Student: joining soon Research Outline: Development of efficient and flexible synthetic accesses to therapeutic natural products and clinical agents for drug discovery and process innovation |
Nancy Sanchez, Undergraduate Student (Class of 2022, Major-Chemistry) Research Outline: Organic synthesis and medicinal chemistry studies of therapeutic natural products and clinical drugs |
Samantha Sakells, Undergraduate Student (Class of 2022, BUILDing Scholar, Major-Bioscience) Research Outline: Biochemical and cellular assay studies of novel tubulin polymerization inhibitors as antimitotic cancer treatment |
Elkin Libo Romero, Ph.D., Graduate Student 06/2017-05/2021
(New position: Senior Research Scientist, Albany Molecular Research Inc., Albany, NY) Doctoral Dissertation: Organic Synthesis Studies for Addressing Clinical Conundrums of Drug Bioactivation and for Facilitating Natural Product Drug Discovery M.S. 2014, B.S. 2010 Universidad del Valle (Cali, Colombia) Like all Colombian, Libo is a big soccer fan; unlike most Colombian, Libo does not drink coffee |
Post-Doc Researcher:
Srinivas Kolluru (09/2018-08/2019) (New position: postdoc at Florida State University) Ph.D. 2018, CSIR-National Chemical Laboratory, Pune, India (Dr. C. V. Ramana) |
Post-Doc Researcher:
Suresh E. Kurhade (04/2017 - 02/2018) (New position: postdoc at University of Kansas) Project : Cardiovascular disease > Antiplatelet inhibitors Ph.D. 2014 Andhra University (Dr. D. Srinivasa Reddy, National Chemical Laboratory); M.S. 2002 University of Pune, India [1st-Author Publication] Org. Biomol. Chem. 2011, 9, 744-7. Tetrahedron Lett. 2011, 52, 4313-5. Synthesis 2011, 21, 3523-9. Org. Lett. 2011, 13, 3690-3. Synthesis, 2013, 45, 1689-92. Over 14 years organic sysnthesis experiences in pharmaceutical industry in India |
Post-Doc Researcher:
Corinne R. Ley (06/2017 - 08/2017) (New position: postdoc at Northwestern University) Project : Cancer > Antitubulin inhibitors Ph.D. 2016 Washington State University (Dr. Cliff Berkman); B.S. 2012 Ohio State University [1st-Author Publication] Bioconj. Chem. 2016, 27, 2206-13. Bioorg. Med. Chem. Lett. 2015, 25, 2536-9. Former NCAA Athlete - OSU Buckeye Women’s Rowing Team Loves tennis, swimming and playing with dog Henry |
Research Associate:
Mingming Zhang (02/2016 - 08/2016) Project : Cancer > Antitubulin inhibitors 2013-2015 Post-doc, School of Pharmacy, University of Hawaii-Hilo (Advisor: Dr. Dianqing Sun) 2010-2013 Ph.D. Medicinal Chemistry, Fudan University (Advisor: Dr.Yingxia Li) 2007-2010 M.S. Medicinal Chemistry, China Pharmaceutical University (Advisor: Dr. Qidong You) 2003-2007 B.S. Pharmacy, China Pharmaceutical University |
Research Associate:
Xiaodong Ren (01/2016 - 08/2016) Project : Cardiovascular disease > Antiplatelet inhibitors 2011-2015 Ph.D. Medicinal Chemistry, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (Advisor: Dr. Shishan Yu) 2008-2011 M.S. Medicinal Chemistry, China Pharmaceutical University (Advisor: Dr. Zhiyu Li) 2004-2008 B.S. Pharmacy, China Pharmaceutical University |
Elizabeth Noriega (undergraduate) 2018-2019
Angel Sanca
(undergraduate, RISE undergraduate Research Scholar) 2017-2019
Nohemi Trevino-Garrido (4 months technician) 2018
Jeffrey Richards (2.5 months technician; 1.5 months rotation student on TA support) 2017
Mark Grant (undergraduate) 2015-2016
Xiuming Cao (11 months visiting scholar) 2016
Lei Ma (4 months rotation student on TA support) 2016
Yulu Ge (4 months rotation student on TA support) 2016
Rui Zeng (3 months visiting scholar) 2016
Sudahkar Kalagara (voluntary research associate) 2015